Genomtec S.A.
GMT.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | PLN 1 | PLN 1 | PLN 40 | PLN 219 |
| % Growth | 0% | -97.5% | -81.7% | – |
| Cost of Goods Sold | PLN 2,330 | PLN 794 | PLN 857 | PLN 595 |
| Gross Profit | PLN 1 | -PLN 793 | -PLN 817 | -PLN 376 |
| % Margin | 100% | -79,300% | -2,042.5% | -171.7% |
| R&D Expenses | PLN 4,310 | PLN 793 | PLN 3,240 | PLN 4,832 |
| G&A Expenses | PLN 4,150 | PLN 9,430 | PLN 8,568 | PLN 5,151 |
| SG&A Expenses | PLN 4,150 | PLN 9,430 | PLN 7,896 | PLN 5,332 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | -PLN 672 | PLN 181 |
| Other Operating Expenses | PLN 2,596 | -PLN 2,289 | PLN 0 | PLN 0 |
| Operating Expenses | PLN 11,056 | PLN 7,934 | PLN 11,136 | PLN 10,164 |
| Operating Income | -PLN 11,055 | -PLN 8,727 | -PLN 11,953 | -PLN 10,540 |
| % Margin | -1,105,500% | -872,700% | -29,882.5% | -4,812.8% |
| Other Income/Exp. Net | -PLN 133 | -PLN 304 | PLN 71 | -PLN 115 |
| Pre-Tax Income | -PLN 11,188 | -PLN 9,031 | -PLN 11,882 | -PLN 7,110 |
| Tax Expense | PLN 20 | -PLN 18 | PLN 46 | PLN 5 |
| Net Income | -PLN 11,208 | -PLN 9,013 | -PLN 11,928 | -PLN 7,115 |
| % Margin | -1,120,800% | -901,300% | -29,820% | -3,248.9% |
| EPS | -0.84 | -0.74 | -1.27 | -0.87 |
| % Growth | -13.5% | 41.7% | -46% | – |
| EPS Diluted | -0.84 | -0.74 | -1.27 | -0.87 |
| Weighted Avg Shares Out | 13,343 | 12,180 | 9,364 | 8,159 |
| Weighted Avg Shares Out Dil | 13,343 | 12,258 | 9,364 | 8,159 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 73 | PLN 64 | PLN 0 | PLN 0 |
| Interest Expense | PLN 134 | PLN 236 | PLN 292 | PLN 28 |
| Depreciation & Amortization | PLN 2,330 | PLN 1,156 | PLN 436 | PLN 504 |
| EBITDA | -PLN 8,725 | -PLN 7,756 | -PLN 11,056 | -PLN 6,578 |
| % Margin | -872,500% | -775,600% | -27,640% | -3,003.7% |